1. Home
  2. PNTG vs COLL Comparison

PNTG vs COLL Comparison

Compare PNTG & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Pennant Group Inc.

PNTG

The Pennant Group Inc.

SELL

Current Price

$40.31

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

SELL

Current Price

$21.48

Market Cap

1.2B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PNTG
COLL
Founded
2019
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
PNTG
COLL
Price
$40.31
$21.48
Analyst Decision
Strong Buy
Buy
Analyst Count
7
8
Target Price
$46.83
★ $49.00
AVG Volume (30 Days)
384.7K
★ 772.3K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 20.00
N/A
EPS
★ 0.49
N/A
Revenue
★ $947,705,000.00
$780,567,000.00
Revenue This Year
$24.90
$6.73
Revenue Next Year
$7.79
$1.37
P/E Ratio
$81.94
★ N/A
Revenue Growth
★ 36.31
23.62
52 Week Low
$22.26
$21.43
52 Week High
$42.74
$50.79

Technical Indicators

Market Signals
Indicator
PNTG
COLL
Relative Strength Index (RSI) 53.92 31.38
Support Level $37.81 $21.54
Resistance Level $41.07 $23.69
Average True Range (ATR) 1.38 0.63
MACD 0.02 0.22
Stochastic Oscillator 64.36 23.56

Price Performance

Historical Comparison
PNTG
COLL

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: